Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis

[1] Rusch V(1996)The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors Cytokine Growth Factor Rev 7 133-141

[2] Mendelsohn J(2006)Metabolism and excretion of erlotinib, a small molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers Drug Metab Dispos Biol Fate Chem 34 420-426

[3] Dmitrovsky E(2008)Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity J Clin Oncol 26 1119-1127

[4] Ling J(2006)Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancer Clin Lung Cancer 8 S7-S14

[5] Johnson KA(2007)Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System Pharmacogenomics 8 293-305

[6] Miao Z(2011)A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling Br J Haematol 154 529-533

[7] Rakhit A(2011)Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study Cancer Biol Ther 12 780-787

[8] Pantze MP(2012)DMET-analyzer: automatic analysis of Affymetrix DMET data BMC Bioinform 13 258-336

[9] Hamilton M(2011)Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D Annu Rev Pharmacol Toxicol 51 311-804

[10] Lum BL(2015)Vitamin D and the skin: focus on a complex relationship: a review J Adv Res 6 793-103

[1] Rusch V(1996)The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors Cytokine Growth Factor Rev 7 133-141

[2] Mendelsohn J(2006)Metabolism and excretion of erlotinib, a small molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers Drug Metab Dispos Biol Fate Chem 34 420-426

[3] Dmitrovsky E(2008)Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity J Clin Oncol 26 1119-1127

[4] Ling J(2006)Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancer Clin Lung Cancer 8 S7-S14

[5] Johnson KA(2007)Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System Pharmacogenomics 8 293-305

[6] Miao Z(2011)A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling Br J Haematol 154 529-533

[7] Rakhit A(2011)Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study Cancer Biol Ther 12 780-787

[8] Pantze MP(2012)DMET-analyzer: automatic analysis of Affymetrix DMET data BMC Bioinform 13 258-336

[9] Hamilton M(2011)Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D Annu Rev Pharmacol Toxicol 51 311-804

[10] Lum BL(2015)Vitamin D and the skin: focus on a complex relationship: a review J Adv Res 6 793-103